However, a further in depth-characterization of the cellular and molecular basis of the NKG2D-NKG2DL interaction and of relevant tumor escape mechanisms is critical for the rational development of novel NKG2D-based immunotherapeutic approaches. This evidence concerns the gene KLRK1 and neoplasm.